Pediatric Colorectal Disorders

An umbrella page, on the same organizing logic as Obstructed Defecation Syndrome (ODS) and General Postoperative Complications: this single ASCRS chapter surveys several distinct pediatric colorectal conditions rather than treating any one in the textbook-chapter depth given to their adult counterparts elsewhere on this wiki, so the content is consolidated here rather than split into many thin pages. Opens Part VI: Miscellaneous of the ASCRS Textbook. Most of this wiki's existing content (fecal incontinence, constipation, rectal prolapse, anal fissure, perianal abscess/fistula) is written from an adult-surgery perspective; this page exists specifically to capture where pediatric disease, evaluation, and management diverge from that adult picture, and cross-references the existing adult pages throughout rather than duplicating shared material.

Hirschsprung's disease (HD)

Congenital absence of ganglion cells in the distal bowel, creating a functional obstruction. Classically presents in one of three windows: the neonatal period (failure to pass meconium in the first 24 hours, with vomiting/distention/feeding intolerance), an early infancy presentation (marginal feeding tolerance followed by enterocolitis — explosive/bloody stool, vomiting, fever), or a late presentation (around weaning or the transition to solids, with significant abdominal distention and a dilated colon on contrast studies, often with a laxative-dependent history).

Diagnosis: rests with the pathologist — absence of ganglion cells more than 1 cm proximal to the dentate line is diagnostic. Suction rectal biopsy, partial-thickness punch biopsy, or full-thickness biopsy are all acceptable depending on age/anesthetic needs; calretinin immunohistochemistry has eliminated the older need for second-opinion confirmation via H&E or acetylcholinesterase assay. Anorectal manometry (looking for the rectoanal inhibitory reflex, RAIR) can be a triage tool for which patients need biopsy, but is unreliable in the first 12 months of life (sensitivity 75-90%) — a notable pediatric-specific caveat versus the adult manometry literature on Anorectal Physiology Testing. If no meconium passes in the first 48 hours, workup includes a barium enema for a transition zone plus rectal biopsy.

Treatment principle: bring ganglionated bowel to within 1 cm of the dentate line. The three classic operations (Swenson, Soave, Duhamel — all can now be performed laparoscopically or transanally/perineally) each address the internal-sphincter dysfunction that accompanies HD via a different modification:

Swenson: full-thickness circumferential rectal resection, ganglionated bowel brought to the distal 1 cm.
Soave: submucosal transanal dissection with anastomosis 1 cm above the dentate line, leaving a small aganglionic cuff. The Boley modification creates an angled/elliptical anastomosis (with a built-in posterior sphincterotomy) to combat distal sphincter dysfunction and stricture.
Duhamel: leaves a segment of aganglionic rectum, with ganglionated bowel anastomosed end-to-back just above the dentate line (also building in a posterior internal sphincterotomy). Any aganglionic segment proximal to the anastomosis must be resected, or it can dilate into a "rectal spur" over time. Often chosen for longer-segment disease where retaining some (aganglionic) rectum aids continence.

With these modifications, all three procedures have equivalent success rates; minimally invasive approaches show shorter length of stay, fewer postoperative complications, and less narcotic use, with no significant difference between laparoscopic and transanal/perineal approaches specifically. Swenson/Soave both carry a stricture risk (from residual aganglionic wall) that may need postoperative dilation; Duhamel's specific risk is the rectal spur described above.

Complication workup follows a systematic ladder: rectal irrigations/dilations/laxatives first → contrast enema if symptoms recur → repeat rectal biopsy to confirm ganglion cells are actually present in the neorectum (a false-negative pathology reading, or loss of ganglion cells from chronic distention, both require a repeat pull-through) → anal dilation, internal sphincter Botox injection, or sphincterotomy if ganglion cells are present but the neorectum remains dilated → laparoscopic spur resection for a symptomatic Duhamel spur.

Hirschsprung-associated enterocolitis (HAEC) is common regardless of surgical approach (~50% have ≥1 episode postoperatively, 20% have >4), with etiology still debated — proposed mechanisms span internal sphincter achalasia to abnormal bacterial processing by HD bowel, and microbiome composition (which total colon resection itself can alter) is an active research area. Increasing HAEC episodes correlate with worse long-term continence. Initial treatment is retrograde rectal saline irrigation plus antibiotics; family teaching of home irrigation can avoid diversion in resistant families and provides a self-management tool if HAEC recurs. Most children "outgrow" recurrent HAEC after age 5.

Adult/long-term outcomes: fecal incontinence in ~15% and constipation in ~5% of adults with repaired HD, though bowel-related quality of life does not appear to be correspondingly reduced; concerns are higher with longer-segment disease (total colonic vs. standard rectosigmoid aganglionosis), and function has been reported to worsen with age in some series (though this "optimistic outcomes" picture has been contested by more recent data showing persistent adult constipation/incomplete evacuation). Sacral nerve stimulation is an emerging adjunctive option in selected patients (see Fecal Incontinence for the adult-population SNM technique/outcome detail this draws on).

Colonic duplications

Rare (1 in 100,000 live births; 1 in 4,500 autopsies) congenital anomaly, 60-80% presenting in the first 2 years of life; colon/rectum duplications make up 17% of all enteric duplications. No single confirmed embryologic mechanism — leading theories include split notochord (traction diverticula from notochord/endoderm splitting, explaining associated spinal anomalies), failed bowel recanalization, and abortive twinning. Duplications are usually tubular or cystic, may be only partially mucosa-lined, and can contain ectopic gastric/pancreatic mucosa (risking ulceration/bleeding/perforation). Hindgut (colonic/rectal) duplications typically share a blood supply and musculature with contiguous bowel, usually on the mesenteric side. Rectal duplications are typically presacral and can be part of a Currarino triad (anorectal stenosis, presacral mass, sacral anomalies); long or distal duplications carry a higher risk of genitourinary/spinal fistulae and anomalies, warranting preoperative contrast and endoscopic evaluation.

Imaging: ultrasound is first-line in infants (a double-walled cyst suggests enteric duplication vs. a simple cyst); CT/MRI define extent and relationship to spine/GU tract.

Treatment: complete excision is the goal but not always feasible or ideal — a small child with a complete colonic duplication may tolerate partial resection with long stapled fenestrations (creating common lumen communication between native and duplicated bowel) better than a total colectomy. Any fistula to the GU tract, spine, or perineum must be excised. Isolated rectal duplications can usually be separated from the native rectal wall and excised entirely; an infected rectal duplication should be drained externally (not internally) to protect the plane between native rectum and duplication. Cystic small-bowel duplications generally require resection with the adjacent mesentery (cyst excision alone leaves an unreliable mesentery), whereas long tubular duplications favor creating a common lumen (fenestration or linear stapling) over lengthy resection.

Pediatric constipation

Common (onset in the first year of life in 17-40% of children); trajectory is generally favorable — 50% recover off laxatives within 6-12 months of gastroenterology referral, 50% off laxatives by 5 years, 80% by 10 years — though delayed initial referral (>3 months of symptoms) predicts delayed recovery. Peak presentation ages are the neonatal period, toilet-training (2-4 years), and school entry (when social pressure around fecal incontinence increases). Contributing organic factors include celiac disease, lactose intolerance, and behavioral/musculoskeletal conditions (autism, cerebral palsy) associated with slow-transit constipation and anismus.

History/workup: time to first meconium passage is a key discriminator for HD (documented passage within 24 hours makes HD very unlikely; delayed passage beyond 48 hours prompts barium enema and rectal biopsy). When surgery is being considered for medically refractory constipation with no identified organic cause, a sitz marker study (colonic transit) and colonic manometry (in children >2) help distinguish colonic inertia (markers throughout the colon) from pelvic floor dysfunction (markers stacked at the puborectalis), and manometry specifically can help predict response to antegrade flushes.

Surgical options: resecting a single dysfunctional bowel segment identified on manometry can improve antegrade-flush efficacy in some patients (not all). For suspected anismus, anal/pelvic floor Botox can serve both diagnostic and therapeutic roles. Sacral nerve stimulation (SNS) for constipation alone has a high failure rate and is not well supported by adult data either (see Constipation for the adult SNM literature) — it is more often placed for a urinary indication with constipation improvement as a secondary benefit. Refractory cases progress to cecostomy/antegrade continence enema (ACE) access (see below), and ultimately to fecal diversion if all else fails.

Constipation-related complications: chronic refractory constipation can progress to colonic volvulus (cecal, transverse, or sigmoid — age-averaged 7 years for sigmoid resection) or, if ischemia/dilation progresses far enough, perforation (most often cecal, per the law of Laplace). Transverse/sigmoid volvulus can sometimes be de-torsed colonoscopically to allow elective bowel preparation; definitive treatment is segmental resection and anastomosis, with attention to the risk of a second volvulus at another colonic segment postoperatively. Acute intestinal pseudo-obstruction (Ogilvie's syndrome) is a separate perforation risk, often precipitated by infection, pancreatitis, electrolyte derangement, or a respiratory process (see Colonic Pseudo-Obstruction (Ogilvie Syndrome) for the adult-population detail).

Pediatric rectal prolapse

An intussusception of the rectum, by definition full-thickness, though infants/small children with various congenital conditions can have a mucosa-only ("mucosal") prolapse. Peak incidence is the first year of life, with most other cases occurring under age 4 or around toilet training; prolapse is a symptom of an underlying condition (usually constipation, but also increased abdominal pressure from straining/chronic cough, diarrhea, parasites, malnutrition, cystic fibrosis, or pelvic floor weakness) rather than a primary diagnosis.

Natural history and initial management: most cases are mild and resolve spontaneously with conservative constipation management (stool softeners/laxatives, avoiding prolonged straining, proper toilet sizing); manual reduction is performed before edema makes it difficult. ~90% of prolapse in children under 4 resolves conservatively, rarely persisting past age 6; children older than 4 are less likely to respond to conservative treatment and are more likely to have an underlying neurologic (spinal cord lesion) or muscular cause requiring intervention. Children being considered for surgery should be screened for cystic fibrosis given an 11.1% prevalence of prolapse in CF patients.

First-line interventional treatment: per a 2018 APSA survey, injection of sclerosant is the most common initial local intervention — mechanistically similar to rubber band ligation for hemorrhoids, creating submucosal (or, per some practitioners, trans-serosal) scarring to prevent further prolapse. Reported agents and cure rates: 30% saline (83% after one injection, 97% after two), 5% phenol in almond oil (91% after one, 100% after two — though one death from phenol toxicity is reported), and 70% ethanol (96% after one, 98% after two). Complications across these agents include temporary incontinence, temporary limping, bleeding, perirectal inflammation, urinary retention, mucosal necrosis, and abscess.

Other minimally invasive/perineal options: anal encirclement (Thiersch procedure) — an absorbable circumferential suture (e.g. 1-0 PDS) tied over a calibrated Hegar dilator — is favored for prolapse from weak pelvic floor musculature or cystic fibrosis. Linear cauterization (a form of local rectopexy creating submucosal scar via electrocautery) has a reported 94% success rate. A combined "modified Thiersch" approach (linear cauterization + sclerotherapy + Thiersch) reported 67% success with a single procedure vs. 90% with the combined approach.

Operative options for refractory cases: Altemeier perineal proctosigmoidectomy or abdominal rectopexy (see Rectal Prolapse Repair for the adult-population technique detail these draw on, noting Altemeier can cause temporary postoperative incontinence in children too). A posterior sagittal rectopexy has been used ambulatory with minimal pain but up to 25% recurrence; Ekehorn's rectosacropexy (adding a U-shaped suture through the rectal ampulla tied at the sacrococcygeal junction) is the only technique in the cited literature reporting zero recurrence; a transcoccygeal rectopexy with puborectalis plication reported 70% success but risked sigmoid intussusception requiring resection. Abdominal rectopexy is now considered first-line for irreversible/full-thickness prolapse, with or without concurrent sigmoidectomy depending on response to simple pexy alone — laparoscopic rectopexy has a ~5% recurrence rate with constipation as essentially the only reported complication, and laparoscopic sigmoid resection with rectopexy (despite historical controversy in children) has been shown safe with low morbidity/recurrence, eliminating volvulus risk; resection rectopexy is preferred for children with intractable constipation and prolonged transit studies, mirroring the adult approach-selection logic on Rectal Prolapse Repair.

Perianal abscess and fistula-in-ano (pediatric)

Distinct epidemiology and natural history from the adult disease covered on Anorectal Abscess/Anal Fistula: most common under age 2 (estimated 0.5-4.3% of all children affected), strongly male-predominant in that age group (12:1 male:female under 2, falling to 2-3:1 after age 2) — proposed mechanisms include in-utero androgen effects on perineal glands and entrapped urogenital-sinus migratory cells during perineal development. Most common at right/left lateral positions. Cultured organisms show a sex association: female abscesses more often grow skin flora (streptococci, S. aureus), male abscesses more often grow enteric flora (E. coli, Klebsiella, enterococci, Proteus) — though mixed enteric organisms don't reliably predict fistula presence.

Management is genuinely unsettled in the literature, with wide variation in both fistula development rates after abscess drainage (20-85% reported) and in whether fistula-in-ano even needs surgery in this age group — spontaneous resolution rates of 17-80% within 1 year are reported, with antibiotic use not affecting spontaneous resolution. In children under 2 specifically, only 15-25% of those undergoing abscess surgery actually have a demonstrable fistula at the time — raising the question of whether an aggressive intraoperative fistula search is worth the sphincter-injury risk in very small patients. Nonoperative management (hygiene, sitz baths, ± antibiotics, needle aspiration for fluctuant collections) is increasingly favored for early/uncomplicated disease, reserving incision and drainage for failure to resolve — one stepwise institutional protocol reported only 8% recurrent abscess and 11% subsequent fistula with a needle-aspiration-first approach. Children over 8 years old behave more like adults, with a high recurrence rate (50%) and fistula-progression rate (25%), supporting a different (more proactive — upfront surgery, or fibrin glue after sepsis clears) strategy in that older group.

Red flags warranting further workup: a child older than 12 months with a recurrent fistula should be evaluated for underlying immunosuppression or inflammatory bowel disease (pediatric Crohn's disease has been diagnosed as young as age 2) before undertaking fistula repair — biologics/immunosuppressive therapy, not surgery, is first-line in that population once sepsis is temporized with drainage ± seton.

Pediatric anal fissure

Common complication of constipation, typically presenting around age 2 (though possible at any age), with rectal pain, crying with defecation, hematochezia, or visible blood. Most common in the posterior midline in general, but anterior midline fissures are more common in females specifically — a distinct epidemiologic note versus the adult literature on Anal Fissure. Off-midline or multiple fissures should prompt biopsy to exclude Crohn's disease, malignancy, tuberculosis, STI, or immunodeficiency; fissures also occur secondary to prior anorectal surgery for congenital anomalies (imperforate anus, persistent cloaca, HD, ileoanal pull-through, cystic fibrosis).

Treatment ladder mirrors the adult approach with pediatric-specific trial data: most spontaneous fissures heal with medical bowel management (10-95% healing rates depending on regimen intensity/duration). Three randomized trials of topical 2% glyceryl trinitrate (GTN) exist: two showed short- and longer-term improvement over placebo (82-84% healing, 91-94% symptomatic relief in the GTN arm vs. 43-50%/10-35% for placebo), while a third (Kenny et al.) found no difference between GTN and placebo (84% healing in both arms). Botulinum toxin (including a transcutaneous needle-free technique) has shown fissure resolution in trials. Anal dilation has not been shown beneficial for chronic constipation in double-blind RCTs. Internal anal sphincter myectomy relieves symptoms in ~2/3 of patients but carries a delayed fecal-incontinence risk that may not manifest for years; botulinum toxin injection achieves comparable resolution to myectomy (94% vs. 89%) without that long-term risk. Lateral subcutaneous sphincterotomy achieved complete resolution in one small series, but any sphincter-directed surgery in a small child/infant carries reported incontinence/anal stenosis rates up to 30% and should be undertaken with extreme caution, with inpatient observation to confirm genuinely painful defecation before committing to surgery.

Cecostomy and antegrade continence enemas (ACE)

Direct percutaneous or surgical access to the cecum for daily antegrade flushing, used in pediatric patients as an alternative to colostomy for achieving social fecal continence — the pediatric counterpart to the adult ACE content on Fecal Incontinence and Low Anterior Resection Syndrome (LARS). First described by Malone in 1990 (MACE — using the appendix, wrapped in a cecal antireflux tunnel, brought to the abdominal wall, typically at the umbilicus); if no appendix is available, a cecal flap or spiraled small-bowel segment can be used instead. Alternative access methods: a surgically-sewn cecostomy with a tube/low-profile gastrostomy device, or a percutaneously (surgically or radiographically) placed cecostomy — Dr. Peter Chait's low-profile self-retaining coiled tube is a commonly cited example.

Comparative trade-offs: an appendicostomy (MACE/ACE) allows the catheter to be removed between flushes (no permanent foreign body, better cosmesis via the umbilical location) but risks aperture stenosis and appendiceal injury/infection; a percutaneous tube stays in place (no daily tract manipulation) but is a permanent foreign body with granulation-tissue and dislodgement risk, and may need sedation for tube exchange. Outcomes and continence rates are reported as roughly equivalent between approaches, with mixed evidence on superiority. Skin-level complications (leakage, infection) are common to all approaches.

Predicting success: a trial of retrograde (regular) enemas that succeeds predicts that antegrade access will also succeed; colonic manometry is a useful adjunct. Patients with generalized dysmotility or a poor response to a bisacodyl challenge are less likely to succeed with cecostomy. A typical postoperative flush regimen escalates to ~20 mL/kg normal saline nightly via gravity, with the child sitting on the toilet for roughly 45 minutes; additives (irritant laxatives, lubricants, promotility agents) can be added if saline alone is insufficient. Children with cerebral palsy or other movement/communication disorders are at higher risk for refractory constipation/soiling due to dysmotility. Sacral nerve stimulation is increasingly used adjunctively in cecostomy patients who also have a urinary indication for SNS — in that population, 45% ultimately had their cecostomy closed after SNS improved bowel symptoms, though SNS placed for constipation alone (not urinary) has a high failure rate and more research is needed.

Common complications reaching an adult provider: excessive granulation tissue (topical steroids or silver nitrate), ACE stenosis (local surgical flap, e.g. V-Y advancement), Chait-tube skin stenosis (local dilation), or ACE prolapse (local surgical revision, taking care to preserve the tenuous appendiceal/conduit blood supply). Retrograde MACE leakage in a non-severely-constipated patient suggests antireflux-mechanism failure requiring revision.

Anorectal malformation (ARM) and Hirschsprung's disease: transitional care

Included here because these congenital conditions increasingly present to adult colorectal surgeons as the pediatric-surgery population ages — a genuine and growing gap in continuity of care that pediatric and adult teams are still working out.

ARM: a wide severity spectrum (congenital anal stenosis to cloaca), incidence ~1 in 2,000-4,000 live births. Bowel dysfunction severity correlates with fistula level — higher fistulas (e.g. rectal-bladder-neck or cloaca) carry worse bowel outcomes, likely from incomplete pelvic floor embryologic development plus associated anomalies (60% of ARM patients have associated GU, skeletal, or spinal anomalies). Long-term issues: 30% urinary incontinence, ~10% male erectile dysfunction, 15% ejaculatory dysfunction (female sexual dysfunction rates are explicitly noted as not adequately studied — see Sexual Function After Colorectal Surgery for the adult literature this gap sits alongside). Standard repair is a posterior sagittal anorectoplasty in infancy. 30-50% of patients with more proximal fistulas are constipated postoperatively (stimulant laxatives preferred over osmotic, since osmotic agents worsen fecal leakage in patients with compromised sphincter function); ~20% of ARM adults report weekly fecal incontinence episodes, managed with a diet/fiber/antimotility-agent combination, with SNS a reasonable option if at least one S3 nerve root is intact (many have sacral anomalies), and cecostomy/ACE access after medical management fails.

HD transitional considerations: 85% of HD has ganglion cells in the rectosigmoid (short-segment, resectable transanally or intra-abdominally); long-segment disease (ganglion cells not identified until proximal to the middle colic vessels) requires an intra-abdominal approach, often with adjunctive laparoscopy to find the transition zone while minimizing sphincter trauma. Historical data suggested optimistic long-term bowel function (only movement frequency differing from non-HD controls), but this has been contested by more recent series finding persistent adult constipation/incomplete evacuation, with some concern that function may deteriorate further with age — an evidence gap the chapter explicitly flags, particularly for transanal endorectal pull-through long-term outcomes.

Process: transitional care should begin discussion at age 12, with an identified adult provider, clear pediatric-adult communication (ideally a joint visit), and completed transition between ages 16-21 — framed explicitly as "a clearly executed transition rather than a drift away from pediatric care." Other pediatric populations likely to eventually need an adult colorectal surgeon: inflammatory bowel disease, familial adenomatous polyposis, mitochondrial cytopathy, colonic inertia, and pelvic floor dysfunction — most transition via an adult GI provider rather than going directly to colorectal surgery.

Fecal Incontinence and Low Anterior Resection Syndrome (LARS) — the adult ACE/cecostomy and sacral neuromodulation literature this page's pediatric sections parallel and cross-reference.
Constipation — the adult slow-transit/dyssynergic-defecation and SNM-for-constipation literature underlying this page's pediatric constipation and SNS-for-constipation sections.
Rectal Prolapse Repair and Rectal Prolapse (Procidentia) — the adult rectopexy technique detail this page's pediatric rectal prolapse section draws on and departs from.
Anorectal Abscess and Anal Fistula — the adult perianal sepsis literature this page's distinctly different pediatric epidemiology and management-uncertainty section contrasts with.
Anal Fissure — the adult treatment ladder this page's pediatric-specific trial data (GTN RCTs, myectomy-vs-Botox) extends.
Anorectal Physiology Testing — the adult manometry/RAIR literature this page's "ARM unreliable under 12 months of age" caveat is a pediatric-specific exception to.
Sexual Function After Colorectal Surgery — shares the "female sexual dysfunction understudied" evidence gap, here in the ARM-transitional-care context rather than adult oncologic surgery.

Open items / gaps

Female sexual dysfunction after ARM repair is explicitly flagged by the source chapter as not adequately studied — an unresolved evidence gap, not a wiki gap.
No consensus exists in the literature on management of pediatric perianal abscess/fistula-in-ano; the chapter's own institutional stepwise algorithm is presented as one reasonable approach among several, not a guideline.
SNS for pediatric constipation specifically (not urinary-indication-with-secondary-bowel-benefit) remains understudied, per the chapter's own explicit statement.
Long-term/adult bowel-function outcomes after transanal endorectal pull-through for HD are flagged by the chapter as needing further data, given conflicting findings across cited series.
No wiki-independent primary trial data yet for any intervention above — all extracted as secondary chapter summary.

Colorectal LLM Wiki